Related Experiment Video
Updated: Jun 29, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Coffee modulates insulin-hepatocyte nuclear factor-4α-Cyp7b1 pathway and reduces oxysterol-driven liver toxicity in a
Genta Kakiyama1,2, Kei Minowa1,3, Daniel Rodriguez-Agudo1,2
1Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia.
Abstract:
Oxysterol 7α-hydroxylase (CYP7B1) controls the levels of intracellular regulatory oxysterols generated by the "acidic pathway" of cholesterol metabolism. Previously, we demonstrated that an inability to upregulate CYP7B1 in the setting of insulin resistance leads to the accumulation of cholesterol metabolites such as (25R)26-hydroxycholesterol (26HC) that initiate and promote hepatocyte injury; followed by an inflammatory response. The current study demonstrates that dietary coffee improves insulin resistance and restores Cyp7b1 levels in a well-characterized Western diet (WD)-induced nonalcoholic fatty liver disease (NAFLD) mouse model. Ingestion of a WD containing caffeinated (regular) coffee or decaffeinated coffee markedly reduced the serum ALT level and improved insulin resistance. Cyp7b1 mRNA and protein levels were preserved at normal levels in mice fed the coffee containing WD. Additionally, coffee led to upregulated steroid sulfotransferase 2b1 (Sult2b1) mRNA expression. In accordance with the response in these oxysterol metabolic genes, hepatocellular 26HC levels were maintained at physiologically low levels. Moreover, the current study provided evidence that hepatic Cyp7b1 and Sult2b1 responses to insulin signaling can be mediated through a transcriptional factor, hepatocyte nuclear factor (HNF)-4α. We conclude coffee achieves its beneficial effects through the modulation of insulin resistance. Both decaffeinated and caffeinated coffee had beneficial effects, demonstrating caffeine is not fundamental to this effect. The effects of coffee feeding on the insulin-HNF4α-Cyp7b1 signaling pathway, whose dysregulation initiates and contributes to the onset and progression of NASH as triggered by insulin resistance, offer mechanistic insight into approaches for the treatment of NAFLD.NEW & NOTEWORTHY This study demonstrated dietary coffee prevented the accumulation of hepatic oxysterols by maintaining Cyp7b1/Sult2b1 expression in a diet-induced NAFLD mice model. Lowering liver oxysterols markedly reduced inflammation in the coffee-ingested mice. Caffeine is not fundamental to this effect. In addition, this study showed Cyp7b1/Sult2b1 responses to insulin signaling can be mediated through a transcriptional factor, HNF4α. The insulin-HNF4α-Cyp7b1/Sult2b1 signaling pathway, which directly correlates to the onset of NASH triggered by insulin resistance, offers insight into approaches for NAFLD treatment.
Insights
Dietary coffee, even decaffeinated, improved insulin resistance and nonalcoholic fatty liver disease (NAFLD) in mice. Coffee maintained oxysterol metabolism by regulating Cyp7b1/Sult2b1 expression, reducing liver inflammation.
Area of Science:
- Metabolic disease research
- Hepatology
- Cholesterol metabolism
Background:
- Insulin resistance disrupts cholesterol metabolism, leading to hepatocyte injury via oxysterols like 26HC.
- Oxysterol 7α-hydroxylase (CYP7B1) dysfunction in insulin resistance promotes liver damage.
Purpose of the Study:
- To investigate the effects of dietary coffee on insulin resistance and nonalcoholic fatty liver disease (NAFLD) in a mouse model.
- To determine if coffee consumption impacts oxysterol metabolism and related gene expression.
Main Methods:
- Utilized a Western diet-induced NAFLD mouse model.
- Administered caffeinated or decaffeinated coffee in the diet.
- Assessed insulin resistance, serum ALT levels, and hepatic Cyp7b1 and Sult2b1 mRNA and protein expression.
- Measured hepatocellular 26HC levels and investigated the role of HNF-4α.
Main Results:
- Dietary coffee (caffeinated and decaffeinated) improved insulin resistance and reduced ALT levels in NAFLD mice.
- Coffee consumption maintained normal Cyp7b1 and Sult2b1 expression and lowered hepatocellular 26HC levels.
- Coffee upregulated Sult2b1 mRNA and implicated HNF-4α in mediating Cyp7b1/Sult2b1 responses to insulin signaling.
Conclusions:
- Dietary coffee mitigates NAFLD by improving insulin resistance and modulating oxysterol metabolism through the HNF-4α-Cyp7b1/Sult2b1 pathway.
- Caffeine is not essential for coffee's beneficial effects on NAFLD.
- Coffee's impact on this pathway offers potential therapeutic strategies for NAFLD treatment.

